The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global De Novo Sequencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genome Survey
1.2.3 Gene Annotation
1.2.4 Evolution Analysis
1.2.5 Auxiliary Assembly
1.3 Market by Application
1.3.1 Global De Novo Sequencing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Hereditary Disease Detection
1.3.4 Life Science
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global De Novo Sequencing Market Perspective (2018-2029)
2.2 De Novo Sequencing Growth Trends by Region
2.2.1 Global De Novo Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 De Novo Sequencing Historic Market Size by Region (2018-2023)
2.2.3 De Novo Sequencing Forecasted Market Size by Region (2024-2029)
2.3 De Novo Sequencing Market Dynamics
2.3.1 De Novo Sequencing Industry Trends
2.3.2 De Novo Sequencing Market Drivers
2.3.3 De Novo Sequencing Market Challenges
2.3.4 De Novo Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top De Novo Sequencing Players by Revenue
3.1.1 Global Top De Novo Sequencing Players by Revenue (2018-2023)
3.1.2 Global De Novo Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global De Novo Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by De Novo Sequencing Revenue
3.4 Global De Novo Sequencing Market Concentration Ratio
3.4.1 Global De Novo Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by De Novo Sequencing Revenue in 2022
3.5 De Novo Sequencing Key Players Head office and Area Served
3.6 Key Players De Novo Sequencing Product Solution and Service
3.7 Date of Enter into De Novo Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 De Novo Sequencing Breakdown Data by Type
4.1 Global De Novo Sequencing Historic Market Size by Type (2018-2023)
4.2 Global De Novo Sequencing Forecasted Market Size by Type (2024-2029)
5 De Novo Sequencing Breakdown Data by Application
5.1 Global De Novo Sequencing Historic Market Size by Application (2018-2023)
5.2 Global De Novo Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America De Novo Sequencing Market Size (2018-2029)
6.2 North America De Novo Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America De Novo Sequencing Market Size by Country (2018-2023)
6.4 North America De Novo Sequencing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe De Novo Sequencing Market Size (2018-2029)
7.2 Europe De Novo Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe De Novo Sequencing Market Size by Country (2018-2023)
7.4 Europe De Novo Sequencing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific De Novo Sequencing Market Size (2018-2029)
8.2 Asia-Pacific De Novo Sequencing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific De Novo Sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific De Novo Sequencing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America De Novo Sequencing Market Size (2018-2029)
9.2 Latin America De Novo Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America De Novo Sequencing Market Size by Country (2018-2023)
9.4 Latin America De Novo Sequencing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa De Novo Sequencing Market Size (2018-2029)
10.2 Middle East & Africa De Novo Sequencing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa De Novo Sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa De Novo Sequencing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10X Genomics Inc.
11.1.1 10X Genomics Inc. Company Detail
11.1.2 10X Genomics Inc. Business Overview
11.1.3 10X Genomics Inc. De Novo Sequencing Introduction
11.1.4 10X Genomics Inc. Revenue in De Novo Sequencing Business (2018-2023)
11.1.5 10X Genomics Inc. Recent Development
11.2 Abcam Plc
11.2.1 Abcam Plc Company Detail
11.2.2 Abcam Plc Business Overview
11.2.3 Abcam Plc De Novo Sequencing Introduction
11.2.4 Abcam Plc Revenue in De Novo Sequencing Business (2018-2023)
11.2.5 Abcam Plc Recent Development
11.3 Exeter Clinical Laboratory
11.3.1 Exeter Clinical Laboratory Company Detail
11.3.2 Exeter Clinical Laboratory Business Overview
11.3.3 Exeter Clinical Laboratory De Novo Sequencing Introduction
11.3.4 Exeter Clinical Laboratory Revenue in De Novo Sequencing Business (2018-2023)
11.3.5 Exeter Clinical Laboratory Recent Development
11.4 Psomagen
11.4.1 Psomagen Company Detail
11.4.2 Psomagen Business Overview
11.4.3 Psomagen De Novo Sequencing Introduction
11.4.4 Psomagen Revenue in De Novo Sequencing Business (2018-2023)
11.4.5 Psomagen Recent Development
11.5 BGI Genomics Co. Ltd.
11.5.1 BGI Genomics Co. Ltd. Company Detail
11.5.2 BGI Genomics Co. Ltd. Business Overview
11.5.3 BGI Genomics Co. Ltd. De Novo Sequencing Introduction
11.5.4 BGI Genomics Co. Ltd. Revenue in De Novo Sequencing Business (2018-2023)
11.5.5 BGI Genomics Co. Ltd. Recent Development
11.6 Bio Rad Laboratories Inc.
11.6.1 Bio Rad Laboratories Inc. Company Detail
11.6.2 Bio Rad Laboratories Inc. Business Overview
11.6.3 Bio Rad Laboratories Inc. De Novo Sequencing Introduction
11.6.4 Bio Rad Laboratories Inc. Revenue in De Novo Sequencing Business (2018-2023)
11.6.5 Bio Rad Laboratories Inc. Recent Development
11.7 Danaher Corp.
11.7.1 Danaher Corp. Company Detail
11.7.2 Danaher Corp. Business Overview
11.7.3 Danaher Corp. De Novo Sequencing Introduction
11.7.4 Danaher Corp. Revenue in De Novo Sequencing Business (2018-2023)
11.7.5 Danaher Corp. Recent Development
11.8 Eppendorf AG
11.8.1 Eppendorf AG Company Detail
11.8.2 Eppendorf AG Business Overview
11.8.3 Eppendorf AG De Novo Sequencing Introduction
11.8.4 Eppendorf AG Revenue in De Novo Sequencing Business (2018-2023)
11.8.5 Eppendorf AG Recent Development
11.9 Eurofins Scientific SE
11.9.1 Eurofins Scientific SE Company Detail
11.9.2 Eurofins Scientific SE Business Overview
11.9.3 Eurofins Scientific SE De Novo Sequencing Introduction
11.9.4 Eurofins Scientific SE Revenue in De Novo Sequencing Business (2018-2023)
11.9.5 Eurofins Scientific SE Recent Development
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Detail
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. De Novo Sequencing Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in De Novo Sequencing Business (2018-2023)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Development
11.11 CD Genomics
11.11.1 CD Genomics Company Detail
11.11.2 CD Genomics Business Overview
11.11.3 CD Genomics De Novo Sequencing Introduction
11.11.4 CD Genomics Revenue in De Novo Sequencing Business (2018-2023)
11.11.5 CD Genomics Recent Development
11.12 Illumina
11.12.1 Illumina Company Detail
11.12.2 Illumina Business Overview
11.12.3 Illumina De Novo Sequencing Introduction
11.12.4 Illumina Revenue in De Novo Sequencing Business (2018-2023)
11.12.5 Illumina Recent Development
11.13 qGenomics
11.13.1 qGenomics Company Detail
11.13.2 qGenomics Business Overview
11.13.3 qGenomics De Novo Sequencing Introduction
11.13.4 qGenomics Revenue in De Novo Sequencing Business (2018-2023)
11.13.5 qGenomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details